BDBM39631 (4-ethoxyphenyl)-(1-propyl-2-benzimidazolyl)methanol::(4-ethoxyphenyl)-(1-propylbenzimidazol-2-yl)methanol::MLS000115791::SMR000092807::cid_628205::p-phenetyl-(1-propylbenzimidazol-2-yl)methanol

SMILES CNC(=O)c1ccc2cc1Nc1nc(ncc1C(F)(F)F)Nc1ccc(OC)c(c1)OC/C=C/CCO2

InChI Key InChIKey=FPRFPKKBBMYQFO-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39631   

TargetSerine/threonine-protein kinase ULK1(Human)
Salk Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 39631BDBM39631(US12594277, Compound 22)
Affinity DataIC50: 20nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2026
Entry Details
US Patent